Lavender (EDTA), pink (K2EDTA), or serum separator tube. OR CSF, bronchoalveolar lavage (BAL), amniotic fluid, vesicle fluid, ocular fluid, tissue. OR endocervical specimen in ThinPrep Pap Test media.
Container
Specimen Preparation
Separate plasma or serum from cells. Transfer 1 mL plasma, serum, CSF, BAL, amniotic fluid, ocular fluid or ThinPrep specimen to a sterile container. (Min: 0.5 mL) Tissue: Transfer to a sterile container and freeze immediately. Vesicle fluid: Transfer to viral transport media (ARUP supply #12884). Available online through eSupply using ARUP Connect™or contact ARUP Client Services at (800) 522-2787.
Unacceptable Conditions
Heparinized specimens, tissues in optimal cutting temperature compound.
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or test-specific nucleic acid in concentrations below the level of detection by this test.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Methodology
Qualitative Polymerase Chain Reaction (PCR)
CPT Codes
87529 x2
Collection
Alias
Epic: LABS20500; ARUP: 2010095
Collect
Lavender (EDTA), pink (K2EDTA), or serum separator tube. OR CSF, bronchoalveolar lavage (BAL), amniotic fluid, vesicle fluid, ocular fluid, tissue. OR endocervical specimen in ThinPrep Pap Test media.
Container
Specimen Preparation
Separate plasma or serum from cells. Transfer 1 mL plasma, serum, CSF, BAL, amniotic fluid, ocular fluid or ThinPrep specimen to a sterile container. (Min: 0.5 mL) Tissue: Transfer to a sterile container and freeze immediately. Vesicle fluid: Transfer to viral transport media (ARUP supply #12884). Available online through eSupply using ARUP Connect™or contact ARUP Client Services at (800) 522-2787.
Unacceptable Conditions
Heparinized specimens, tissues in optimal cutting temperature compound.
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or test-specific nucleic acid in concentrations below the level of detection by this test.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratories.